Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Neurologic complications of acute hepatitis E virus infection.

Ripellino P, Pasi E, Melli G, Staedler C, Fraga M, Moradpour D, Sahli R, Aubert V, Martinetti G, Bihl F, Bernasconi E, Terziroli Beretta-Piccoli B, Cerny A, Dalton HR, Zehnder C, Mathis B, Zecca C, Disanto G, Kaelin-Lang A, Gobbi C.

Neurol Neuroimmunol Neuroinflamm. 2019 Dec 5;7(1). pii: e643. doi: 10.1212/NXI.0000000000000643. Print 2020 Jan.

2.

Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.

Gitto S, Bihl F, Schepis F, Caputo F, Berenguer M.

Biomed Res Int. 2019 Jul 9;2019:8691502. doi: 10.1155/2019/8691502. eCollection 2019. No abstract available.

3.

Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.

Gitto S, Marra F, De Maria N, Bihl F, Villa E, Andreone P, Burra P.

Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):173-178. doi: 10.1080/17474124.2019.1551132. Epub 2018 Nov 30. Review.

PMID:
30791778
4.

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?

Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Robbins Scott S, Semela D, Negro F.

PLoS One. 2018 Dec 31;13(12):e0209374. doi: 10.1371/journal.pone.0209374. eCollection 2018.

5.

Autoimmune liver disease serology in acute hepatitis E virus infection.

Terziroli Beretta-Piccoli B, Ripellino P, Gobbi C, Cerny A, Baserga A, Di Bartolomeo C, Bihl F, Deleonardi G, Melidona L, Grondona AG, Mieli-Vergani G, Vergani D, Muratori L; Swiss Autoimmune Hepatitis Cohort Study Group.

J Autoimmun. 2018 Nov;94:1-6. doi: 10.1016/j.jaut.2018.07.006. Epub 2018 Jul 7.

PMID:
30336842
6.

Antibiotic administration after cholecystectomy for acute mild-moderate cholecystitis: a PRISMA-compliant meta-analysis.

La Regina D, Di Giuseppe M, Cafarotti S, Saporito A, Ceppi M, Mongelli F, Bihl F, Balzarotti Canger RC, Ferrario di Tor Vajana A.

Surg Endosc. 2019 Feb;33(2):377-383. doi: 10.1007/s00464-018-6498-0. Epub 2018 Oct 16.

PMID:
30327917
7.

Sulfoximines as potent RORγ inverse agonists.

Ouvry G, Bihl F, Bouix-Peter C, Christin O, Defoin-Platel C, Deret S, Feret C, Froude D, Hacini-Rachinel F, Harris CS, Hervouet C, Lafitte G, Luzy AP, Musicki B, Orfila D, Parnet V, Pascau C, Pascau J, Pierre R, Raffin C, Rossio P, Spiesse D, Taquet N, Thoreau E, Vatinel R, Vial E, Hennequin LF.

Bioorg Med Chem Lett. 2018 May 1;28(8):1269-1273. doi: 10.1016/j.bmcl.2018.03.041. Epub 2018 Mar 17.

PMID:
29571573
8.

Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis.

Ouvry G, Atrux-Tallau N, Bihl F, Bondu A, Bouix-Peter C, Carlavan I, Christin O, Cuadrado MJ, Defoin-Platel C, Deret S, Duvert D, Feret C, Forissier M, Fournier JF, Froude D, Hacini-Rachinel F, Harris CS, Hervouet C, Huguet H, Lafitte G, Luzy AP, Musicki B, Orfila D, Ozello B, Pascau C, Pascau J, Parnet V, Peluchon G, Pierre R, Piwnica D, Raffin C, Rossio P, Spiesse D, Taquet N, Thoreau E, Vatinel R, Vial E, Hennequin LF.

ChemMedChem. 2018 Feb 20;13(4):321-337. doi: 10.1002/cmdc.201700758. Epub 2018 Feb 6.

PMID:
29327456
9.

A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant.

Zhang L, Pereira Mestre R, Bihl F, Bühler M, Vannata B, Stathis A.

Case Rep Oncol. 2017 Oct 17;10(3):923-927. doi: 10.1159/000481452. eCollection 2017 Sep-Dec.

10.

Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.

Terziroli Beretta-Piccoli B, Stirnimann G, Cerny A, Semela D, Hessler R, Helbling B, Stickel F, Kalid-de Bakker C, Bihl F, Giostra E, Filipowicz Sinnreich M, Oneta C, Baserga A, Invernizzi P, Carbone M, Mertens J.

Clin Rev Allergy Immunol. 2018 Apr;54(2):295-306. doi: 10.1007/s12016-017-8656-x.

PMID:
29181702
11.

Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.

Fraga M, Doerig C, Moulin H, Bihl F, Brunner F, Müllhaupt B, Ripellino P, Semela D, Stickel F, Terziroli Beretta-Piccoli B, Aubert V, Telenti A, Greub G, Sahli R, Moradpour D.

Liver Int. 2018 Apr;38(4):619-626. doi: 10.1111/liv.13557. Epub 2017 Sep 7.

12.

Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.

Bruggmann P, Negro F, Bihl F, Blach S, Lavanchy D, Müllhaupt B, Razavi H, Semela D.

Swiss Med Wkly. 2015 Dec 4;145:w14221. doi: 10.4414/smw.2015.14221. eCollection 2015.

13.

NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.

Luci C, Bekri S, Bihl F, Pini J, Bourdely P, Nouhen K, Malgogne A, Walzer T, Braud VM, Anjuère F.

PLoS One. 2015 Dec 2;10(12):e0143224. doi: 10.1371/journal.pone.0143224. eCollection 2015.

14.

Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.

Germain C, Guillaudeux T, Galsgaard ED, Hervouet C, Tekaya N, Gallouet AS, Fassy J, Bihl F, Poupon G, Lazzari A, Spee P, Anjuère F, Pangault C, Tarte K, Tas P, Xerri L, Braud VM.

Oncoimmunology. 2015 Apr 8;4(8):e1026503. eCollection 2015 Aug.

15.

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.

Bihl F, Martinetti G, Wandeler G, Weber R, Ledergeber B, Calmy A, Battegay M, Cavassini M, Vernazza P, Caminada AP, Rickenbach M, Bernasconi E; Swiss HIV Cohort Study.

BMC Gastroenterol. 2015 Jul 8;15:79. doi: 10.1186/s12876-015-0308-0.

16.

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.

Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F.

PLoS One. 2015 Jun 24;10(6):e0125214. doi: 10.1371/journal.pone.0125214. eCollection 2015.

17.

NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors.

Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, Motomura Y, Moreira-Santos L, Bihl F, Braud V, Kee B, Brady H, Coles MC, Vosshenrich C, Kubo M, Di Santo JP, Veiga-Fernandes H.

Cell Rep. 2015 Mar 31;10(12):2043-54. doi: 10.1016/j.celrep.2015.02.057. Epub 2015 Mar 19.

18.

Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland.

Bordoni A, Cerny A, Bihl F, Alerci M, Mazzola P, Peverelli S, Marini G, Majno P, Mazzucchelli L, Spitale A.

Cancer Epidemiol. 2014 Dec;38(6):679-85. doi: 10.1016/j.canep.2014.09.008. Epub 2014 Oct 17.

PMID:
25454980
19.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
20.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
21.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
22.

Adaptive response in hepatitis B virus infection.

Loggi E, Gamal N, Bihl F, Bernardi M, Andreone P.

J Viral Hepat. 2014 May;21(5):305-13. doi: 10.1111/jvh.12255. Epub 2014 Mar 27. Review.

PMID:
24674098
23.

Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study.

Wandeler G, Gsponer T, Bihl F, Bernasconi E, Cavassini M, Kovari H, Schmid P, Battegay M, Calmy A, Egger M, Furrer H, Rauch A; Swiss HIV Cohort Study.

J Infect Dis. 2013 Nov 1;208(9):1454-8. doi: 10.1093/infdis/jit351. Epub 2013 Jul 30.

24.

Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells.

Hervouet C, Luci C, Bekri S, Juhel T, Bihl F, Braud VM, Czerkinsky C, Anjuère F.

Mucosal Immunol. 2014 Mar;7(2):280-91. doi: 10.1038/mi.2013.45. Epub 2013 Jun 26.

PMID:
23801305
25.

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.

Loggi E, Bihl FK, Cursaro C, Granieri C, Galli S, Brodosi L, Furlini G, Bernardi M, Brander C, Andreone P.

PLoS One. 2013 Jun 4;8(6):e65327. doi: 10.1371/journal.pone.0065327. Print 2013.

26.

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, Panno AM, Bernardi M, Brander C, Bihl F, Andreone P, Maini MK.

J Hepatol. 2013 Feb;58(2):225-33. doi: 10.1016/j.jhep.2012.09.029. Epub 2012 Oct 6.

PMID:
23046671
27.

B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.

Anjuère F, Bekri S, Bihl F, Braud VM, Cuburu N, Czerkinsky C, Hervouet C, Luci C.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:117-22. doi: 10.1111/j.1469-0691.2012.03995.x. Epub 2012 Aug 10. Review.

28.

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.

Girardin F, Daali Y, Gex-Fabry M, Rebsamen M, Roux-Lombard P, Cerny A, Bihl F, Binek J, Moradpour D, Negro F, Desmeules J; Swiss Hepatitis C Cohort Study Group.

J Viral Hepat. 2012 Aug;19(8):568-73. doi: 10.1111/j.1365-2893.2011.01578.x. Epub 2012 Jan 26.

PMID:
22762141
29.

Health-related quality of life outcomes after cholecystectomy.

Carraro A, Mazloum DE, Bihl F.

World J Gastroenterol. 2011 Dec 7;17(45):4945-51. doi: 10.3748/wjg.v17.i45.4945. Review.

30.

Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.

Loggi E, Micco L, Ercolani G, Cucchetti A, Bihl FK, Grazi GL, Gitto S, Bontadini A, Bernardi M, Grossi P, Costa AN, Pinna AD, Brander C, Andreone P.

J Hepatol. 2012 Mar;56(3):579-85. doi: 10.1016/j.jhep.2011.09.016. Epub 2011 Oct 23.

PMID:
22027583
31.

Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Bihl F, Germain C, Luci C, Braud VM.

Cell Mol Life Sci. 2011 Nov;68(21):3457-67. doi: 10.1007/s00018-011-0796-1. Epub 2011 Aug 23. Review.

PMID:
21861183
32.

[Management of the cirrhotic patient].

Pfefferle M, Bihl F, Terziroli B, Cerny A.

Ther Umsch. 2011 Apr;68(4):207-11. doi: 10.1024/0040-5930/a000152. Review. German.

PMID:
21452142
33.

Cell biology and immunology of Leishmania.

Mougneau E, Bihl F, Glaichenhaus N.

Immunol Rev. 2011 Mar;240(1):286-96. doi: 10.1111/j.1600-065X.2010.00983.x. Review.

PMID:
21349100
34.

Characterization of alternatively spliced transcript variants of CLEC2D gene.

Germain C, Bihl F, Zahn S, Poupon G, Dumaurier MJ, Rampanarivo HH, Padkjær SB, Spee P, Braud VM.

J Biol Chem. 2010 Nov 12;285(46):36207-15. doi: 10.1074/jbc.M110.179622. Epub 2010 Sep 14.

35.

Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection.

Bihl F, Pecheur J, Bréart B, Poupon G, Cazareth J, Julia V, Glaichenhaus N, Braud VM.

J Immunol. 2010 Aug 15;185(4):2174-81. doi: 10.4049/jimmunol.1001486. Epub 2010 Jul 12.

36.

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.

Bihl F, Russmann S, Gurtner V, Di Giammarino L, Pizzi-Bosman L, Michel M, Cerny A, Hadengue A, Majno P, Giostra E, Castelli D, Mentha G.

BMC Gastroenterol. 2010 Jul 4;10:71. doi: 10.1186/1471-230X-10-71.

37.

Hepatic amyloidosis increases liver stiffness measured by transient elastography.

Janssens F, Spahr L, Rubbia-Brandt L, Giostra E, Bihl F.

Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):52-4.

PMID:
20458851
38.

Hepatitis E virus: a zoonosis adapting to humans.

Bihl F, Negro F.

J Antimicrob Chemother. 2010 May;65(5):817-21. doi: 10.1093/jac/dkq085. Epub 2010 Mar 23. Review.

PMID:
20335188
39.

[An update on the management of chronic hepatitis C].

Bihl F, Pache I, Hess J, Moradpour D.

Rev Med Suisse. 2010 Jan 27;6(233):174, 176-9. French.

PMID:
20214188
40.

The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians.

Bihl F, Alaei M, Negro F.

Swiss Med Wkly. 2010 Mar 20;140(11-12):154-9. doi: smw-12969.

41.

Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.

Bihl F, Janssens F, Boehlen F, Rubbia-Brandt L, Hadengue A, Spahr L.

BMC Gastroenterol. 2010 Jan 18;10:6. doi: 10.1186/1471-230X-10-6.

42.

Treatment of chronic hepatitis C.

Bihl F, Negro F.

Minerva Med. 2009 Dec;100(6):459-65. Review.

PMID:
20010481
43.

[What's new in the treatment of hepatitis B infection?].

Bihl F, Alaei M, Girardin M, Negro F.

Rev Med Suisse. 2009 Sep 2;5(215):1720-2, 1724. French.

PMID:
19803224
44.

[Portal hypertension and HIV infection].

Spahr L, Bihl F, Rubbia-Brandt L, Hadengue A.

Rev Med Suisse. 2009 Sep 2;5(215):1696-8, 1700. French.

PMID:
19803220
45.

Acute hepatitis due to brivudin: a case report.

Mottu A, Rubbia-Brandt L, Bihl F, Hadengue A, Spahr L.

J Hepatol. 2009 Nov;51(5):967-9. doi: 10.1016/j.jhep.2009.06.017. Epub 2009 Jul 10.

46.

Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.

Bihl F, Berger C, Chisholm JV 3rd, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ; Swiss HIV Cohort Study.

AIDS. 2009 Sep 10;23(14):1918-22. doi: 10.1097/QAD.0b013e3283300a91.

47.

Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.

Gasser O, Bihl F, Sanghavi S, Rinaldo C, Rowe D, Hess C, Stablein D, Roland M, Stock P, Brander C.

Am J Transplant. 2009 Apr;9(4):794-803. doi: 10.1111/j.1600-6143.2008.02539.x.

48.

Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.

Loggi E, Bihl F, Chisholm JV 3rd, Biselli M, Bontadini A, Vitale G, Ercolani G, Grazi GL, Pinna AD, Bernardi M, Brander C, Andreone P.

J Hepatol. 2009 Mar;50(3):625-30. doi: 10.1016/j.jhep.2008.08.026. Epub 2008 Dec 25.

49.

Chronic hepatitis E in the immunosuppressed: a new source of trouble?

Bihl F, Negro F.

J Hepatol. 2009 Feb;50(2):435-7. doi: 10.1016/j.jhep.2008.11.007. Epub 2008 Dec 4. No abstract available.

PMID:
19070913
50.

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.

Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM.

Hepatology. 2008 Dec;48(6):1769-78. doi: 10.1002/hep.22549.

Supplemental Content

Support Center